CUREDirexion Daily Healthcare Bull 3x Shares
CURE Fund Description
CURE provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies.
CURE Factset Analytics Insight
As a levered product, CURE is not a buy-and-hold ETF; it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare names—like J&J, Pfizer, and Merck—in the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. CURE's expense ratio is high but, as a short-term product, yearly fees are less important than trading costs. Liquidity is decent, although spreads can be volatile. Check the latest Tradability data on this page.
CURE Charts And Performance
CURE Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CURE. CURE is rated a N/A out of 5.